Main > ONCOLOGY (**) > UK. I. Eye>Uveal Melanoma>Treat.>

---

UK. I. Eye>Uveal Melanoma>Treat.>'s subsections
(*) USA Approval Date: 2022. 01.26
>TCR
Company
Generic Name
HLA-A*02:01-positive
RTM
RTM Web-Site
unresectable or metastatic
USA Patent Number

UK. I. Eye>Uveal Melanoma>Treat.>'s products
This section has no products